Proteostasis Therapeutics Inc. withdrew its previously announced underwritten public offering of 9 million common shares.
The Cambridge, Mass.-based biopharma company said "current market conditions are not conducive for an offering."
Proteostasis withdraws stock offering due to market conditions
Gauging Supply Chain Risk In Volatile Times
Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals
The Future of Risk Management Digitization in Credit Risk Management
Climate Credit Analytics: Diving into the model
Proteostasis withdraws stock offering due to market conditions
- Author Vince Iral
- Theme Healthcare & Pharmaceuticals
- Author
- Vince Iral
- Theme
- Healthcare & Pharmaceuticals